Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome [5] (multiple letters)

Sander Veldhuyzen Van Zanten, Eamonn M.M. Quigley, Liam O'Mahony, Fergus Shanahan

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)772-773
Number of pages2
Issue number2
StatePublished - Aug 2005

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this